Overview
Pacmed builds clinical decision support systems that help doctors choose personalized treatments. Using artificial intelligence, the platform analyzes patient medical data and routine care information to generate relevant treatment suggestions for physicians. The system is designed to improve both patient outcomes and hospital efficiency by providing data-driven, individualized guidance at the point of care. Compared with its peers, Pacmed emphasizes applying AI to everyday clinical data to enhance decision making and care quality, supported by investors focused on health innovation. The company aims to help medical professionals make more accurate, individualized decisions and to raise the overall quality and efficiency of healthcare organizations.
Work here?Claim your company
Simplify's take
What believers are saying
- Gelre ziekenhuizen signed ICU implementation in November 2025, expanding commercial traction.
- Pacmed and ChipSoft launched HiX integration in July 2025, widening sales reach.
- BovenIJ, Amsterdam UMC, and Santeon keep providing live reference sites and data.
What critics are saying
- Pacmed expects another funding round before profitability, signaling continued cash dependence.
- HiX integrations at Gelre and Zuyderland remain announced, not broadly deployed.
- If Dutch hospital procurement slows, Pacmed stalls before causal-inference products ship.
What makes Pacmed unique
- Pacmed Critical is embedded in Dutch ICUs, not generic hospital software.
- ChipSoft HiX integration gives Pacmed distribution across 76% of Dutch hospitals.
- Clinical models are validated with Amsterdam UMC, Santeon, CZ, and Zilveren Kruis.
Help us improve and share your feedback! Did you find this helpful?